Inactive Instrument

MusclePharm Corporation Share Price Other OTC

Equities

Duration

Period

Style

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	18/10/23	CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	09/10/23	CI
Motion for Asset Sale Approved for MusclePharm Corporation	03/10/23	CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	26/09/23	CI
Stalking Horse Agreement Filed by MusclePharm Corporation	08/09/23	CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director	31/08/23	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	28/08/23	CI
First Amended Disclosure Statement Approved for MusclePharm Corporation	28/08/23	CI
Bidding Procedure Approved for MusclePharm Corporation	17/08/23	CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	19/07/23	CI
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	19/06/23	CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	26/05/23	CI
Motion for Asset Sale Filed by MusclePharm Corporation	12/05/23	CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	10/05/23	CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	16/04/23	CI

SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	28/06/23	AQ
MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	29/09/22	AQ
MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	19/09/22	PU
MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	19/09/22	AQ
MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	23/08/22	AQ

Managers	Title	Age	Since
Eric Hillman CEO	Chief Executive Officer	-	12/02/23
Eric Chin DFI	Director of Finance/CFO	44	16/06/22
Ryan Charles Drexler CHM	Chairman	53	25/08/15

Members of the board	Title	Age	Since
Eric Hillman CEO	Chief Executive Officer	-	12/02/23
Michael Heller BRD	Director/Board Member	48	18/01/21
Ryan Charles Drexler CHM	Chairman	53	25/08/15

MusclePharm Corporation is a United States company. The Company has no operation nor generated any revenue.

Sector

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+195.79%	7.3B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+23.55%	799M
ARES ACQUISITION CORPORATION II	+1.72%	661M
E7 GROUP	+5.92%	653M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M
CAPITOL INVESTMENT CORP. VII	-.--%	500M